Mads Krogsgaard Thomsen, Novo Nordisk Foundation CEO
September 21, 2022 07:43 AM EDT
Deals
AI

No­vo Nordisk Foun­da­tion is­sues $200M grant to ap­ply quan­tum com­put­ing to life sci­ences, drug dis­cov­ery

Max Gelman

Senior Editor

The No­vo Nordisk Foun­da­tion, the large Dan­ish char­i­ty that owns the phar­ma­ceu­ti­cal com­pa­ny of the same name, is mak­ing a quan­tum leap.

Mak­ing a deep …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Halozyme with­draws Evotec ac­qui­si­tion pro­pos­al af­ter biotech is 'un­will­ing to en­gage'

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times